Novo Integrated Sciences Inc (NVOS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Novo Integrated Sciences Inc (NVOS) has a cash flow conversion efficiency ratio of -0.037x as of November 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-545.92K) by net assets ($14.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Novo Integrated Sciences Inc net asset quality index to measure how much of total assets are equity-financed.
Novo Integrated Sciences Inc - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Novo Integrated Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Novo Integrated Sciences Inc to evaluate the quality of earnings relative to operating cash generation.
Novo Integrated Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novo Integrated Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Siam Cement Public Company Limited
F:TCM1
|
0.018x |
|
Walker Crips Group PLC
LSE:WCW
|
-0.456x |
|
Crimson Tide plc
LSE:TIDE
|
-0.014x |
|
TROUBADOUR RESOURCES INC.
F:2QD0
|
-0.017x |
|
Marechale Capital Plc
LSE:MAC
|
-0.059x |
|
Headlam Group
LSE:HEAD
|
-0.182x |
|
Kasikornbank Public Company Limited
F:TFBF
|
0.144x |
|
Empire Metals Limited
LSE:GEO
|
-0.066x |
Annual Cash Flow Conversion Efficiency for Novo Integrated Sciences Inc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Novo Integrated Sciences Inc from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Novo Integrated Sciences Inc (NVOS) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-08-31 | $14.61 Million | $-2.24 Million | -0.154x | -67.64% |
| 2023-08-31 | $24.50 Million | $-2.24 Million | -0.092x | +30.86% |
| 2022-08-31 | $44.43 Million | $-5.88 Million | -0.132x | -466.11% |
| 2021-08-31 | $43.80 Million | $-1.02 Million | -0.023x | -56.63% |
| 2020-08-31 | $29.57 Million | $-441.69K | -0.015x | +53.60% |
| 2019-08-31 | $25.54 Million | $-822.27K | -0.032x | +99.40% |
| 2018-08-31 | $172.77K | $-934.50K | -5.409x | -2961.09% |
| 2017-08-31 | $-4.29 Million | $-810.69K | 0.189x | +1419.42% |
| 2016-09-30 | $-7.08 Million | $101.39K | -0.014x | +99.88% |
| 2016-08-31 | $14.75K | $-175.62K | -11.904x | -5235.68% |
| 2015-08-31 | $-625.67K | $-145.03K | 0.232x | -11.88% |
| 2014-08-31 | $-947.87K | $-249.32K | 0.263x | -40.10% |
| 2013-08-31 | $-797.36K | $-350.12K | 0.439x | +126.25% |
| 2012-08-31 | $-2.33 Million | $-451.84K | 0.194x | -81.37% |
| 2011-08-31 | $-1.49 Million | $-1.55 Million | 1.042x | +30.39% |
| 2010-08-31 | $-1.19 Million | $-951.79K | 0.799x | +273.71% |
| 2009-08-31 | $-1.44 Million | $-307.59K | 0.214x | -62.94% |
| 2008-08-31 | $-844.10K | $-486.89K | 0.577x | -62.45% |
| 2007-08-31 | $-296.61K | $-455.65K | 1.536x | +407.69% |
| 2006-08-31 | $-409.22K | $-123.83K | 0.303x | +21.80% |
| 2005-08-31 | $-305.08K | $-75.79K | 0.248x | 0.00% |
| 2004-08-31 | $-305.08K | $-75.79K | 0.248x | -- |
About Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more